Clinical Trial Update: An Efficacy and Safety Study of Extended Release (ER) Tramadol Hydrochloride (HCl)/Acetaminophen in Participants With Chronic Low-Back Pain [Phase 3]

View source ↗

Summary

A Phase 3 efficacy and safety study of extended-release tramadol hydrochloride/acetaminophen for chronic low-back pain has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Tramadol HCl/acetaminophen extended-release (tramadol hydrochloride and acetaminophen (extended-release))

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2013-07-24